Attached files
file | filename |
---|---|
EX-21 - EX-21 - Microbot Medical Inc. | f55153exv21.htm |
EX-31.2 - EX-31.2 - Microbot Medical Inc. | f55153exv31w2.htm |
EX-32.1 - EX-32.1 - Microbot Medical Inc. | f55153exv32w1.htm |
EX-31.1 - EX-31.1 - Microbot Medical Inc. | f55153exv31w1.htm |
EX-32.2 - EX-32.2 - Microbot Medical Inc. | f55153exv32w2.htm |
EX-10.30 - EX-10.30 - Microbot Medical Inc. | f55153exv10w30.htm |
EX-10.28 - EX-10.28 - Microbot Medical Inc. | f55153exv10w28.htm |
EX-10.24 - EX-10.24 - Microbot Medical Inc. | f55153exv10w24.htm |
EX-10.23 - EX-10.23 - Microbot Medical Inc. | f55153exv10w23.htm |
EX-10.31 - EX-10.31 - Microbot Medical Inc. | f55153exv10w31.htm |
EX-10.27 - EX-10.27 - Microbot Medical Inc. | f55153exv10w27.htm |
EX-10.29 - EX-10.29 - Microbot Medical Inc. | f55153exv10w29.htm |
EX-10.22 - EX-10.22 - Microbot Medical Inc. | f55153exv10w22.htm |
EX-10.32 - EX-10.32 - Microbot Medical Inc. | f55153exv10w32.htm |
10-K - FORM 10-K - Microbot Medical Inc. | f55153e10vk.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our reports dated March 10, 2010, with respect to the consolidated financial
statements and internal control over financial reporting included in the Annual Report of
StemCells, Inc. on Form 10-K for the year ended December 31, 2009. We hereby consent to the
incorporation by reference of said reports in the previously filed Registration Statements of
StemCells, Inc. on Forms S-3 (File Nos. 333-159604, effective May 29, 2009, 333-151891, effective
June 24, 2008 and amended on July 18, 2008, 333-117360, effective July 14, 2004, 333-105664,
effective May 29, 2003 and amended on June 3, 2003, 333-83992, effective on March 8, 2002 and
amended on July 2, 2002, 333-75806, effective December 21, 2001 and amended on January 1, 2009, and
333-66692, effective August 3, 2001 and amended on August 8, 2001) Form S-1 (File No. 333-61726,
effective May 25, 2001 and amended on June 29, 2001 and July 2, 2001) and Forms S-8 (File Nos.
333-10773, effective August 23, 1996, 333-29335, effective June 16, 1997, 333-37313, effective
October 7, 1997, 333-66700, effective August 3, 2001, 333-118263, effective August 16, 2004,
333-144747, effective July 20, 2007, and 33-49524, effective July 10, 1992) and Registration
Statements of CytoTherapeutics, Inc. on Forms S-3 (File Nos. 33-91228, effective April 14, 1995,
and 33-68900, effective September 15, 1993).
/s/ Grant
Thornton LLP
San Francisco, CA
March 10, 2010
March 10, 2010